Yahoo Finance7d
Adagene Inc. (ADAG)
This Phase 1b/2, open-label, multicenter dose escalation and expansion combination stud SAN DIEGO and SUZHOU, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq ...
Business Insider20d
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
SAN DIEGO and SUZHOU, China, March 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies ...
KRON4 News26d
Adagene to Present at Leerink’s Global Healthcare Conference 2025
SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies ...
Nasdaq19d
Adagene Inc. to Present ADG126 SAFEbody® Data at 11th Annual Immuno-Oncology 360⁰ Summit in Boston
Adagene Inc. announced its participation at the 11th Annual Immuno-Oncology 360⁰ Summit in Boston on March 26, 2025, where it will present its clinical program for ADG126, a novel anti-CTLA-4 ...
Mena FN27d
Adagene To Present At Leerink’S Global Healthcare Conference 2025
(MENAFN- GlobeNewsWire - Nasdaq) SAN DIEGO and SUZHOU, China, March 06, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming ...